This nuclear medicine market report forecasts global industry size to reach USD 35.32 Bn by 2031 as therapeutic radiopharmaceuticals grow further and adoption of targeted radiotherapy increases. Asia-Pacific is emerging as the fastest-growing region.
Hyderabad, Feb. 18, 2026 (GLOBE NEWSWIRE) — According to Mordor Intelligence, the nuclear medicine market size is projected to be valued at USD 19.60 billion in 2026 and is anticipated to grow to USD 35.32 billion by 2031, registering a CAGR of 12.5% during the forecast period. Growth is driven by increasing adoption of advanced diagnostic imaging, rising prevalence of cancer and cardiovascular diseases, and expanding use of targeted radiopharmaceutical therapies. Hospitals, diagnostic imaging centers, and specialty clinics are increasingly integrating nuclear medicine technologies to enable earlier disease detection and more precise treatment planning across global healthcare systems. The nuclear medicine market is expanding as demand grows for functional imaging techniques that provide detailed insights into organ performance and disease progression. Modalities such as SPECT and PET imaging are increasingly utilized in oncology, cardiology, and neurology to support accurate diagnosis and therapy monitoring. Radiopharmaceuticals continue to play a central role, enabling clinicians to visualize physiological processes and deliver targeted therapeutic interventions.
Nuclear Medicine Market Share by Region
North America represents a significant share of the nuclear medicine market, supported by advanced imaging infrastructure, high adoption of PET and SPECT systems, and strong research activity in radiopharmaceutical development. The region benefits from established nuclear medicine networks and a growing focus on personalized oncology treatments.
Europe also holds a substantial position in the market, driven by increasing utilization of nuclear imaging procedures and ongoing investments in diagnostic imaging technologies.
Asia-Pacific is emerging as a high-growth region due to expanding healthcare infrastructure, rising awareness of early disease detection, and growing access to advanced imaging services in several countries.
Nuclear Medicine Market Trends and Key Drivers
Rising Adoption of Theranostics
The integration of diagnostic imaging and targeted radiotherapy is enabling more personalized cancer treatment strategies. Theranostic approaches are gaining attention for their ability to improve treatment precision and patient outcomes.
Expansion of Radiopharmaceutical Development
Continuous research into new radioisotopes and tracers is broadening the application scope of nuclear medicine across oncology, cardiology, and neurology. Innovation in radiopharmaceutical production and distribution is further strengthening market growth.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/nuclear-medicine-market?utm_source=globenewswire
Nuclear Medicine Market Segmentation Overview
By Product Type
- Diagnostics
- SPECT
- PET
- Therapeutics
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
By Radioisotope
- Technetium-99m
- Fluorine-18
- Iodine-131
- Lutetium-177
- Others
By Application
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Orthopedics & Pain Management
- Other Applications
By End User
- Hospitals
- Diagnostic Imaging Centers
- Specialized Radiopharmacies
- Research Institutes
- Ambulatory Surgical Centers
By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/nuclear-medicine-market?utm_source=globenewswire
Nuclear Medicine Market Competitive Outlook
The nuclear medicine market features established imaging technology providers and specialized radiopharmaceutical manufacturers. Market participants are focusing on expanding radiotracer portfolios, strengthening supply chains, and investing in advanced imaging systems to meet growing clinical demand. Strategic collaborations and research initiatives are supporting innovation and global market expansion.
Nuclear Medicine Companies Include:
- GE Healthcare
- Cardinal Health Inc.
- Siemens Healthineers
- Novartis AG
- Curium Pharma
Check out related reports published by Mordor Intelligence
Peripheral Vascular Devices Market Size – The peripheral vascular devices market is estimated at USD 14.5 billion in 2026 and is projected to reach USD 17.79 billion by 2031, registering a CAGR of 4.18% during the forecast period. Growth is driven by the rising prevalence of peripheral artery disease, increasing adoption of minimally invasive endovascular procedures, and growing demand for advanced angioplasty and stenting solutions.
Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, Medtronic and Cook are the major companies operating in this market.
Read more about companies active in the peripheral vascular devices market: https://www.mordorintelligence.com/industry-reports/global-peripheral-vascular-devices-market-industry/companies?utm_source=globenewswire
Diabetes Care Devices Market Growth – The diabetes care devices market is estimated to grow from USD 70.02 billion in 2026 to USD 95.9 billion by 2031, at a CAGR of 6.49% over the forecast period. Market expansion is supported by the increasing global burden of diabetes, rising adoption of continuous glucose monitoring systems, and growing preference for home-based diabetes management devices.
Abbott Diabetes Care, Medtronic (Diabetes), Dexcom, Roche Diabetes Care and Insulet Corporation are the major companies operating in this market.
Read more about companies active in the diabetes care devices market: https://www.mordorintelligence.com/industry-reports/global-diabetes-care-devices-market-industry/companies?utm_source=globenewswire
Neurology Devices Market Share – The neurology devices market is estimated at USD 15.82 billion in 2026 and is projected to reach USD 20.02 billion by 2031, growing at a CAGR of 4.80%. Growth is driven by the rising incidence of neurological disorders, increasing demand for neurostimulation and interventional procedures, and advancements in diagnostic and monitoring technologies.
Boston Scientific Corporation, Stryker Corporation, B. Braun Melsungen AG, Medtronic PLC and Abbott Laboratories are the major companies operating in this market.
Read more about companies active in the neurology devices market: https://www.mordorintelligence.com/industry-reports/global-neurology-devices-market-industry/companies?utm_source=globenewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
CONTACT: For any inquiries, please contact: [email protected] https://www.mordorintelligence.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.